Cardinal Health - CAH Stock Forecast, Price & News

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 8 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.
View CAH analyst ratings or view top-rated stocks.

12 equities research analysts have issued 12 month price objectives for Cardinal Health's stock. Their CAH share price forecasts range from $67.00 to $94.00. On average, they expect the company's share price to reach $80.33 in the next twelve months. This suggests a possible upside of 10.9% from the stock's current price.
View analysts price targets for CAH or view top-rated stocks among Wall Street analysts.

Cardinal Health's stock was trading at $76.87 at the start of the year. Since then, CAH shares have decreased by 5.7% and is now trading at $72.46.
View the best growth stocks for 2023 here.

Cardinal Health saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 4,120,000 shares, a drop of 16.9% from the February 28th total of 4,960,000 shares. Based on an average trading volume of 2,530,000 shares, the short-interest ratio is currently 1.6 days. Approximately 1.6% of the company's shares are sold short.
View Cardinal Health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our CAH earnings forecast.

Cardinal Health, Inc. (NYSE:CAH) issued its quarterly earnings data on Thursday, February, 2nd. The company reported $1.32 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.13 by $0.19. The company had revenue of $51.47 billion for the quarter, compared to analysts' expectations of $50.03 billion. Cardinal Health had a negative net margin of 0.66% and a negative trailing twelve-month return on equity of 101.28%. The company's quarterly revenue was up 13.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.27 EPS.
Read the conference call transcript.

Cardinal Health declared a quarterly dividend on Friday, February 10th. Shareholders of record on Monday, April 3rd will be paid a dividend of $0.4957 per share on Saturday, April 15th. This represents a $1.98 annualized dividend and a yield of 2.74%. The ex-dividend date of this dividend is Friday, March 31st.
Read our dividend analysis for CAH.

ETFs with the largest weight of Cardinal Health (NYSE:CAH) stock in their portfolio include First Trust Nasdaq Pharmaceuticals ETF (FTXH), Vesper U.S. Large Cap Short-Term Reversal Strategy ETF (UTRN), LeaderShares AlphaFactor Tactical Focused ETF (LSAT), SEI Enhanced U.S. Large Cap Value Factor ETF (SEIV), USCF Dividend Income Fund (UDI), Invesco DWA Consumer Cyclicals Momentum ETF (PEZ), SRH U.S. Quality ETF (SRHQ) and AAM S&P 500 High Dividend Value ETF (SPDV).

Cardinal Health (NYSE:CAH) pays an annual dividend of $1.98 per share and currently has a dividend yield of 2.82%. The company has been increasing its dividend for 37 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 36.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CAH will have a dividend payout ratio of 31.94% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CAH.

Cardinal Health updated its FY 2023 earnings guidance on Thursday, February, 2nd. The company provided EPS guidance of $5.20-$5.50 for the period, compared to the consensus earnings per share estimate of $5.32. The company issued revenue guidance of -.

357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health's stock is owned by many different retail and institutional investors. Top institutional investors include Geode Capital Management LLC (2.08%), Price T Rowe Associates Inc. MD (1.94%), Morgan Stanley (1.78%), Amundi (1.63%), Arrowstreet Capital Limited Partnership (1.50%) and Norges Bank (1.11%). Insiders that own company stock include Michelle Brennan and Ola M Snow.
View institutional ownership trends.

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CAH stock can currently be purchased for approximately $72.46.

Cardinal Health (NYSE:CAH) has a market capitalization of $18.67 billion and generates $181.36 billion in revenue each year. The company earns $-933,000,000.00 in net income (profit) each year or $5.45 on an earnings per share basis.

The company employs 46,500 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The official website for the company is www.cardinalhealth.com. The company can be reached via phone at (614) 757-5000, via email at investor.relations@cardinalhealth.com, or via fax at 614-757-6000.